UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids
Pathological reprogramming of the m6A epitranscriptome in uterine fibroids is a funding opportunity from UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, up to 647762, closing May 31, 2027.
May 31, 2027
(304d left)Overview
PROJECT SUMMARY/ABSTRACT Uterine fibroids (UFs) are the most important benign neoplastic threat to women’s health worldwide. As no long- term non-invasive treatment option currently exists for UFs, deeper insight into tumor etiology is key to develop more effective therapies. In this regard, while the epi/genetic…